Prostate Cancer Institute of America (PCIA) is revitalizing the use of modern low-dose rate (LDR) prostate brachytherapy across the U.S. With a national expansion strategy, PCIA aims to bring this advanced treatment to more patients, offering a precise and effective option for prostate cancer care.
Leading the efforts on the East Coast is Dr. Manuj Agarwal, a renowned expert in prostate cancer treatment. His leadership is driving the availability of LDR brachytherapy to more men in the region. Meanwhile, in the Midwest, Bobby Koneru, MD, FASTRO, is spearheading the growth of these services, ensuring patients in this area benefit from cutting-edge cancer treatment.
PCIA’s commitment to providing high-quality care ensures that patients across the country have access to this effective and targeted therapy for prostate cancer, reducing the risk of side effects and improving outcomes.
